William E. Rose's most recent trade in Reata Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 500,000 Class A common stock done . Disclosure was reported to the exchange on Aug. 23, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Reata Pharmaceuticals Inc ... | William E. Rose | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Aug 2023 | 500,000 | 379,281 (1%) | 1% | 0 | Class A common stock | |
| Reata Pharmaceuticals Inc ... | William E. Rose | Director, Ten Percent Owner, Member of 10% owner group | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 4,275 | 4,275 | - | - | Stock Option (right-to-buy) | |
| Reata Pharmaceuticals Inc ... | William E. Rose | Director, Ten Percent Owner, Member of 10% owner group | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 1,085 | 1,085 | - | - | Stock Option (right-to-buy) | |
| Reata Pharmaceuticals Inc ... | William E. Rose | Director, Ten Percent Owner, Member of 10% owner group | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 11,240 | 11,240 | - | - | Stock Option (right-to-buy) | |
| Reata Pharmaceuticals Inc ... | William E. Rose | Director, Ten Percent Owner, Member of 10% owner group | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 3,330 | 3,330 | - | - | Stock Option (right-to-buy) |